In humans, LAG-3+ pDCs in melanoma have been implicated in tumor-associated immunosuppression where tumor-associated MHC-II expression induces TLR-independent activation, production of inhibitory cytokines and recruitment of myeloid derived suppressor cells (MDSCs). Here, LAG3 is linked to neoplasm.